tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS

Corvus Pharmaceuticals (CRVS) Financial Statements

474 Followers

Corvus Pharmaceuticals Financial Overview

Corvus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.511; its P/E ratio is -3.95; Corvus Pharmaceuticals is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue--$ -1.28M$ -1.73M-
Gross Profit--$ -1.28M$ -1.73M-
EBIT$ -7.05M$ -6.42M$ -6.91M$ -8.30M-
EBITDA$ -7.03M$ -6.39M$ -6.87M$ -8.25M-
Net Income Common Stockholders$ -6.65M$ -6.00M$ -6.50M$ -7.87M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.15M$ 32.17M$ 37.02M$ 34.47M$ 42.30M
Total Assets$ 45.55M$ 51.94M$ 58.05M$ 57.91M$ 68.24M
Total Debt$ 1.37M$ 1.69M$ 2.00M$ 2.30M$ 2.60M
Net Debt$ -25.77M$ -30.48M$ -35.02M$ -32.16M$ -39.70M
Total Liabilities$ 6.87M$ 7.65M$ 8.56M$ 9.33M$ 12.13M
Stockholders Equity$ 38.68M$ 44.29M$ 49.45M$ 48.83M$ 56.12M
Cash Flow-
Free Cash Flow$ -5.13M$ -5.43M$ -5.22M$ -8.14M-
Operating Cash Flow$ -5.13M$ -5.43M$ -5.22M$ -8.11M-
Investing Cash Flow$ -2.32M$ 17.55M$ -4.29M$ 4.60M-
Financing Cash Flow-$ 335.00K$ 7.52M$ 4.00K-
Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

Corvus Pharmaceuticals Debt to Assets

Corvus Pharmaceuticals Cash Flow

Corvus Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis